Despite a deluge of new information—and a steady stream of microbiome-related studies expanding the available data on human microbiome composition and function—ingredient researchers are only beginning to understand the individual microbial species and their biological roles. Luckily, artificial intelligence (AI) and machine learning are proving to be game changers in our understanding of these expanding datasets.
Technology could bring transformational change through the development of predictive models for personalized therapeutic interventions or disease interception. But before that lofty goal is reached, biotics providers are discovering the impact that bacteria-based ingredients can have on a wide range of health systems beyond gut health, including the gut-brain axis, a connection to healthy skin, and the influence of dysbiosis on host immunity and disease.
The session will cover:
• Innovation in product development across a range of consumer-facing solutions that include prebiotics, probiotics, synbiotics and postbiotics.
• The segment expansion of probiotics into sports nutrition, weight management, inflammation targeting and cosmetics, as well as bone health, women’s health, kidney and respiratory function, cognitive performance, and stress and sleep.
• The accumulation of in vivo and clinical data indicating that probiotics could represent important allies in the fight against obesity and associated metabolic health concerns.
In partnership with:
Underwritten by:
Technology could bring transformational change through the development of predictive models for personalized therapeutic interventions or disease interception. But before that lofty goal is reached, biotics providers are discovering the impact that bacteria-based ingredients can have on a wide range of health systems beyond gut health, including the gut-brain axis, a connection to healthy skin, and the influence of dysbiosis on host immunity and disease.
The session will cover:
• Innovation in product development across a range of consumer-facing solutions that include prebiotics, probiotics, synbiotics and postbiotics.
• The segment expansion of probiotics into sports nutrition, weight management, inflammation targeting and cosmetics, as well as bone health, women’s health, kidney and respiratory function, cognitive performance, and stress and sleep.
• The accumulation of in vivo and clinical data indicating that probiotics could represent important allies in the fight against obesity and associated metabolic health concerns.
- 9:00 – 9:10 Welcome and introductions from George Paraskevakos, IPA
- 9:10 - 9:30 Bethany Henrick, Brightseed: Using AI to discover plant bioactives and map them to specific modes of action
- 9:30 - 9:50 Katarina Doma, KGK Science: From Theory to Research Practice: Study methodologies to investigate synbiotic supplementation on microbial communities, intestinal permeability and other markers of gut health
- 9:50 - 10:10 Barry Skillington, Atlantia Trials: Criteria to consider when conducting a microbiome-based clinical study
- 10:10 - 10:30 Susan Hewlings, Radicle Science: Prebiotic fibers and microbiome modulation
- 10:30 - 10:50 Sandra Saville, International Probiotics Association: Unleashing the hidden power of prebiotics, probiotics and postbiotics on geroscience and aging
- Consumer messaging and retail data
- 10:50 - 11:10 Brandon Casteel, SPINS: Consumer and retail trends in the biotic categories
- 11:10 - 11:30 Asa Waldstein, Supplement Advisory Group: Claims, regulatory compliance and messaging around microbiome ingredients
- 11:30 - 12 PANEL, “Mapping the present and future of the market for microbiome-based ingredients.” Led by moderator Duffy Hayes. PANELISTS: Ralf Jager, Increnovo LLC; Martin Felkner, Finzelberg GmbH & Co. KG; George Paraskevakos, IPA
In partnership with:
Underwritten by:
Date & Time
Thursday October 26th, 2023 9:00am PDT
End Date & Time
Thursday October 26th, 2023 12:00pm PDT
Location
Islander Ballroom C
Category Education Sessions